Search results
U.S. to start offering COVID-19 vaccine booster doses in September
AOL· 6 days agoThe White House is prepared to offer a third booster shot starting on that date to all Americans who...
Pfizer Inc. (NYSE:PFE) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 days agoPfizer Inc. (NYSE:PFE) Q1 2024 Earnings Call Transcript May 1, 2024 Pfizer Inc. beats earnings...
Pfizer lifts profit view on cost cuts, smaller drop in Paxlovid By Reuters
Investing.com· 3 days agoSales of Padcev, a treatment for advanced bladder cancer Pfizer (NYSE:PFE) gained through its $43...
Pfizer plans to be 'very active' in obesity market, but CEO mum on precise R&D plans
FierceBiotech· 3 days agoPfizer’s 2024 revival tour is off and running, but the Big Pharma remains mum on one critical...
US opens COVID vaccine to little kids, shots begin next week
AOL· 4 days agoThe U.S. on Saturday opened COVID-19 vaccines to infants, toddlers and preschoolers. The shots will...
Cardiff Oncology Inc (CRDF) (Q1 2024) Earnings Call Transcript Highlights: Strategic Insights ...
GuruFocus.com via Yahoo Finance· 23 hours agoThe company is leveraging Pfizer Ignite's resources to ensure effective trial execution. Q: Could you read some of the scenario planning that you...Q3/Q4 will include about ...
Increasing the Dose of Smoking Cessation Treatments Improved Abstinence
MedPage Today· 1 day agoAmong participants who were treated with varenicline but were not abstinent, the end-of-treatment...
ESCMID 2024: Highlights on prophylaxis and treatment of infectious diseases
Clinical Trials Arena via Yahoo Finance· 3 days agoThis was compared to 67.2% efficacy for RSV and 78.8% efficacy for severe RSV in adults who had...
Study identifies immunity threshold for protection against COVID-19 in children
Medical Xpress· 4 days agoAll participants received two doses of 10mcg Pfizer/BioNTech mRNA COVID-19 vaccination, 21 days apart. The team followed up with the participants for one year, during which ...
Regeneron Reverses On Better-Than-Feared Eylea Sales
Investor's Business Daily· 1 day agoHigh-dose Eylea came in at $200 million, beating expectations for $189 million, Leerink Partners analyst David Risinger said in a report. The high dose...